March Update: “Rags-To-Riches” Portfolio Down 8.6%

Image Source: Unsplash

The munKNEE “Rags-to-Riches” Portfolio consists of 16 cannabis, psychedelic, and plant-based food stocks with market capitalizations between $400M and $3.0B – an average of $968M. The munKNEE “Multi-bagger” Portfolio, in comparison, consists of the next largest 9 stocks in the same four indexes which have market capitalizations between $75M and $399M with am average of $122M.

An original article by Lorimer Wilson, Managing Editor of munKNEE.com (Your KEY To Making Money!)

Below is an update on how the various categories in the Portfolio, and their constituents, performed in March and have performed YTD.

1. American Cannabis MSO constituents:
   • Columbia Care )CCHWF): DOWN 14.8%; DOWN 30.7% YTD;
   • Cresco (CRLBF): DOWN 10.4% in March; DOWN 11.4% YTD;
   • Curaleaf (CURLF): DOWN 21.9% in March; DOWN 27.9% YTD;
   • Green Thumb (GTBIF): DOWN 7.2% in March; DOWN 8.7% YTD;
   • TerrAscend (TRSSF): DOWN 3.2% in March; UP 38.2% YTD;
   • Trulieve (TCNNF): DOWN 13.1% in March; DOWN 26.1% YTD; and
   • Verano (VRNOF): DOWN 1.7% in March; DOWN 5.2% YTD.
     • In total: DOWN 15.7% in March; DOWN 20.1% YTD and
     • an average 12-month price target of representing a 203% increase from the March 31st price
   • For comparison purposes, the AdvisorShares Pure U.S. Cannabis ETF (MSOS) was DOWN 131% in March; DOWN 18.6% YTD.
2. Canadian Cannabis LP constituents:
   • Canopy Growth (CGC):DOWN 24.2% in March; DOWN 22.9% YTD;;
   • Cronos (CRON): DOWN 1.5% in March; DOWN 23.0% YTD; and
   • Tilray (TLRY): DOWN 10.6% in March; DOWN 5.2% YTD.
     • In total: DOWN 12.5% in March; DOWN 16.6% YTD and
     • an average year-end price target of representing a 57% increase from the March 31st price
   • For comparison purposes, the Global X Cannabis ETF (POTX) was DOWN 15.0% in March; DOWN 18.3% YTD.
3. Psychedelic Drug Stock constituents:
   • Atai (ATAI): UP 7.7% in March; DOWN 29.8% YTD;
   • Compass Pathways (CMPS): UP 7.4%% in March; UP 27.1% YTD;
   • GH Research (GHRS): DOWN 16.6% in March; DOWN 16.2% YTD and
   • Incannex (IXHL): UP 14.5%; DOWN 22.1% YTD.
     • In total: DOWN 0.7% in March; DOWN 3.6% YTD and
     • an average year-end price target of representing a 363% increase from the March 31st price
   • For comparison purposes, the AdvisorShares Psychedelics ETF (PSIL) was DOWN 11.3% in March; UP 1.1% YTD.
4. Plant-Based Food Stock constituents:
   • Beyond Meat (BYND): DOWN 9.0% in March; UP 33.0% YTD; and
   • Oatly Group (OTLY): UP 10.0% in March; UP 39.1% YTD.
     • In total: DOWN 6.9% in March; UP 32.9% YTD and
     • an average year-end price target of representing a 4.4% DECREASE from the March 31st price
   • No comparable plant-based food stock ETFs

In Conclusion

• The “Rags-to-Riches” Portfolio was DOWN 8.6% in March and DOWN 3.9% YTD;
• our “Multi-bagger” Portfolio was UP 5.7% in March and DOWN 12.7% YTD while
• the S&P 500 was UP 5.2% in March and UP 7.0% YTD.

Read More